clinical trial · NCT00647621
Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg
HealthyExtended Phenytoin Sodium Capsules 100 mgDilantin® Kapseals® 100 mg
brief summary
The objective of this study was to investigate the steady-state bioequivalence of Mylan's extended phenytoin sodium capsules, 100mg (3x100mg), to Pfizer's Dilantin® Kapseals®, 100mg (3x100mg), under both fasting and fed conditions.
started
Oct 1, 2005
primary completion
Dec 1, 2005
completion
Dec 1, 2005
last updated
Apr 24, 2024
official title
Steady-State Bioequivalence Study of Extended Phenytoin Sodium Capsules (100 mg; Mylan) and Dilantin® Kapseals® (100 mg; Pfizer) in Healthy Adult Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol